| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.78 | 0.007 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.77 | 0.004 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.75 | 0.01 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.65 | 0.04 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.58 | 0.04 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.4 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.32 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.31 | 0.3 |